Cost overview of the new anti-cancer drug Platinib, current medical insurance situation and guide to legal acquisition methods

Platinib (trade name: Pujihua), a receptor tyrosine kinase inhibitor known for its high efficiency and high selectivityRET inhibitor, has emerged in the field of cancer treatment in recent years. It shows excellent therapeutic effects on RET gene fusion-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) and RET-mutated medullary thyroid carcinoma (MTC), opening up a new treatment path for cancer patients.

The cost of platinib has been a matter of close concern to patients and their families. The original drug is expensive, and the cost of long-term treatment does pose a challenge for ordinary families. Unfortunately, platinib is not currently covered by my country’s national medical insurance system, and patients need to bear all the drug costs themselves. However, the emergence of generic drugs has given patients new hope. Take the generic version of Platinib from Lucius Pharmaceuticals in Laos as an example. Its price is much lower than the original drug, providing patients with a more affordable treatment option.

Patients have several legal options to choose from when it comes to obtaining platinib. First, patients can go to regular pharmacies or hospital pharmacies to buy the medicine with a prescription issued by a doctor. At the same time, some large medical institutions or cancer centers also provide purchasing services for Platinib. These institutions usually have cooperative relationships with pharmaceutical companies and can ensure the quality and supply of drugs. For patients who need to purchase generic drugs, they should purchase them through formal overseas channels and make sure to choose a reputable and legally qualified supplier.

When using platinib, patients should strictly follow the doctor's instructions and understand the correct usage, dosage, and potential adverse reactions of the drug. At the same time, patients should also pay attention to drug interactions and avoid unnecessary risks caused by simultaneous use with other drugs. For special groups, such as pregnant women, lactating women, and those with liver and kidney dysfunction, you need to be extra cautious when using Platinib and strictly follow the doctor's medication recommendations.

In summary, platinib, as a new anti-cancer drug with significant efficacy, provides new treatment hope for RET gene fusion-positive cancer patients. Although its price is higher and it has not yet been included in the medical insurance system, with the launch of generic drugs and the continuous improvement of medical insurance policies, patients will have more choices and less financial pressure when using Platinib. At the same time, patients should purchase drugs through legal channels and use them rationally under the guidance of doctors to ensure the safety and effectiveness of treatment.